<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210101049910N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-03-12</date_registration>
      <primary_sponsor>Semnan University of Medical Sciences</primary_sponsor>
      <public_title>Effects of adding Cognitive-Behavioral Therapy (CBT) to stability exercises in low back pain patients</public_title>
      <acronym></acronym>
      <scientific_title>Effects of adding Cognitive-Behavioral Therapy (CBT) to stability exercises on Lumbo-Pelvic Rhythm during lifting in non-specific low back pain patients with high fear of movement</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-04-03</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>51</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/53420</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Blocks of 3 and 6 are used for randomization. The intervention groups are called A and B; the control group is called C. Different 3 blocks including A, B, C, and 6 different blocks with two A, B, C are defined in different permutations. We will have 3 blocks of 3 and 7 blocks of 6. Each block is assigned a number from 0 to 9. Using a random number generator, the blocks are selected from 10 designated blocks, respectively. Eligible individuals are assigned to one of three groups A, B, or C in each block (from left to right) in a predetermined order.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Non-specific low back pain.</hc_freetext>
      <i_freetext>Intervention 1: First intervention group: Participants in this group will receive stabilization exercises that involve pulling the abdomen in 10 different positions for eight weeks, two days in a week. Patients will be taught how to do the exercises orally and using pictures. The abdominal inhalation practice is held for 10 seconds and is repeated 10 times with a pause of 3 seconds and the time interval of each Practice until the next exercise is 60 seconds. The exercises are progressive and the number of exercises increases over time. Intervention 2: Second intervention group: In addition to trunk stabilization exercises that will be given to the subjects for eight weeks and two sessions per week, cognitive behavioral therapy will also be given to the participants of this group. This treatment is based on problem solving, so in the first stage, the patient is evaluated by the therapist. Evaluation in this treatment aims to collect information that based on the cognitive model, determine how the disorder is formed and its continuation. The psychotherapist examines the patient's mood and asks him or her to make a list of his or her problems, write down his or her thoughts, identify abnormal behaviors, and try to control them. Each week, a treatment session is provided for patients in this group, the first session will be 2 hours and the next sessions will be 30 minutes for 8 weeks. Except for the first session, which is more about introducing the patient to the treatment process, in the next sessions, the therapist and the patient review the previous week and both work together to determine the current agenda. In the treatment sessions, the treatment assignments are reviewed, the current agenda is executed, a new assignment is determined, and at the end of each session, the patient is asked to comment on the session. Intervention 3: Control group: This group will not receive treatment.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There are not more informations.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Rosita Hedayati</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Rehabilitation Faculty, Semnan University of Medical Sciences, 5 kilometer of Damghan Road</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3514799442</zip>
        <telephone>+98 23 3365 4180</telephone>
        <email>rosehed@yahoo.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Rosita Hedayati</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Rehabilitation Faculty, Semnan University of Medical Sciences, 5 kilometer of Damghan Road</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3514799442</zip>
        <telephone>+98 23 3365 4180</telephone>
        <email>rosehed@yahoo.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Non-specific low back pain patients with high fear of movement
At least 12 weeks have passed since the low back pain
Having fear scores greater than 40 on the Tampa scale for kinesiophobia
According to VAS on the day of the study the maximum pain intensity of each patient must be 3</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>55 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Any signs of serious spinal involvement
Having symptoms of cauda equina syndrome
Having symptoms of sciatica
Symptoms of spinal canal stenosis
Symptoms of nerve root involvement
History of spinal surgery
Spinal fracture
Structural abnormalities in the spine
Swelling, inflammation and dryness of the lumbar joints
Having a BMI of more than 25 kg per square meter
Report of uncorrected visual impairment
Severe cognitive and memory impairment
Pregnancy</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M54.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Low back pain</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First intervention group: Participants in this group will receive stabilization exercises that involve pulling the abdomen in 10 different positions for eight weeks, two days in a week. Patients will be taught how to do the exercises orally and using pictures. The abdominal inhalation practice is held for 10 seconds and is repeated 10 times with a pause of 3 seconds and the time interval of each Practice until the next exercise is 60 seconds. The exercises are progressive and the number of exercises increases over time.</i_keyword>
      <i_keyword>Second intervention group: In addition to trunk stabilization exercises that will be given to the subjects for eight weeks and two sessions per week, cognitive behavioral therapy will also be given to the participants of this group. This treatment is based on problem solving, so in the first stage, the patient is evaluated by the therapist. Evaluation in this treatment aims to collect information that based on the cognitive model, determine how the disorder is formed and its continuation. The psychotherapist examines the patient's mood and asks him or her to make a list of his or her problems, write down his or her thoughts, identify abnormal behaviors, and try to control them. Each week, a treatment session is provided for patients in this group, the first session will be 2 hours and the next sessions will be 30 minutes for 8 weeks. Except for the first session, which is more about introducing the patient to the treatment process, in the next sessions, the therapist and the patient review the previous week and both work together to determine the current agenda. In the treatment sessions, the treatment assignments are reviewed, the current agenda is executed, a new assignment is determined, and at the end of each session, the patient is asked to comment on the session.</i_keyword>
      <i_keyword>Control group: This group will not receive treatment.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Lumbo-pelvic rhythm. Timepoint: The first session, last session, and one month after the end of the sessions. Method of measurement: 3D motion analysis system.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Fear of movement. Timepoint: The first session, last session and one month after the end of the sessions for the intervention and control groups. Method of measurement: Tampa scale for kinesiophobia.</sec_outcome>
      <sec_outcome>Disability. Timepoint: The first session, last session and one month after the end of the sessions for the intervention and control groups. Method of measurement: Roland Morris disability questionnaire.</sec_outcome>
      <sec_outcome>Pain. Timepoint: The first session, last session and one month after the end of the sessions for the intervention and control groups. Method of measurement: Visual analog scale.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Semnan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-12-22</approval_date>
        <contact_name>Ethics Committee of Semnan University of Medical Sciences</contact_name>
        <contact_address>Semnan University of Medical Sciences, Basij Blvd, Semnan Semnan Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
